WASHINGTON, D.C., Oct. 12, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC) released their Cancer Cachexia Voice of the Patient Report as a follow-up to their Externally-Led…
SOLANA BEACH, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to…
is a metabolic wasting disorder that affects up to 80% of patients with advanced cancer and is associated with about a third of all deaths from cancer. People with cachexia experience…
Pune, India, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The Cancer Cachexia Market is anticipated to gain traction from the rising shift of the healthcare providers towards combination therapies.…